CVKD Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Cadrenal Therapeutics Inc (CVKD) is not a strong buy for a beginner, long-term investor with $50,000-$100,000 available for investment. The stock lacks significant positive catalysts, has weak financial performance, and no clear trading signals or trends to support a buy decision. A hold is recommended until more favorable indicators emerge.
The MACD is positive and expanding, indicating slight bullish momentum. However, the RSI is neutral at 59.238, and the moving averages are bearish (SMA_200 > SMA_20 > SMA_5). The stock is trading near its resistance level (R1: 6.223), suggesting limited upside potential in the short term.
NULL identified. No recent news or significant insider/hedge fund activity to support a bullish outlook.
The stock's financials are weak, with no revenue, a negative net income of -$2,685,705 (albeit improved YoY), and a significant EPS decline (-39.91% YoY). The stock also shows a 60% chance of minor declines or negligible gains in the short term.
In Q3 2025, the company reported no revenue growth (0% YoY) and a net income of -$2,685,705 (improved by 11.54% YoY). EPS dropped significantly by -39.91% YoY, indicating worsening profitability.
No analyst ratings or price target changes available.
